Company / Assets per Share
Cue Biopharma, Inc. Assets per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$0.68
FY2025
5-year range
$0.68 / $2.83
FY2021-FY2025
Trend
+0.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share returned to growth in FY2025 after 2 years of decline, reaching $0.68.
Based on SEC 10-K filings.
0.68 in FY2025 with a 5-year CAGR of -28.9%.
Declined from $1.30 to $0.68 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -37.8%
- 5-Year CAGR
- -28.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, assets per share increased 0.2% year-over-year.
- Peak assets per share was recorded in FY2020.
- Lowest assets per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -7.60 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.68 | +0.2% |
| FY2024 | $0.68 | -47.7% |
| FY2023 | $1.30 | -54.0% |
| FY2022 | $2.83 | +3.2% |
| FY2021 | $2.75 | -26.7% |
| FY2020 | $3.75 | +8.3% |
| FY2019 | $3.46 | +48.4% |
| FY2018 | $2.33 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026